{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T07:26:02Z","timestamp":1778138762324,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00404-020-05452-2","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T14:02:44Z","timestamp":1584712964000},"page":"1021-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors"],"prefix":"10.1007","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5555-2521","authenticated-orcid":false,"given":"Jinhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuping","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingya","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"issue":"4","key":"5452_CR1","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1172\/JCI71195","volume":"124","author":"I Daehn","year":"2014","unstructured":"Daehn I, Casalena G, Zhang T et al (2014) Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest 124(4):1608\u20131621","journal-title":"J Clin Invest"},{"issue":"8","key":"5452_CR2","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1097\/IGC.0b013e3182236582","volume":"21","author":"G Mangili","year":"2011","unstructured":"Mangili G, Sigismondi C, Gadducci A et al (2011) Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study. Int J Gynecol Cancer 21(8):1414\u20131421","journal-title":"Int J Gynecol Cancer"},{"issue":"9 Suppl 3","key":"5452_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/IGC.0000000000000223","volume":"24","author":"J Brown","year":"2014","unstructured":"Brown J, Friedlander M, Backes FJ, Harter P, O\u2019Connor DM, de la Rouge MT, Lorusso D, Maenpaa J, Kim JW, Tenney ME, Seckl MJ (2014) Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors. Int J Gynecol Cancer 24(9 Suppl 3):48\u201354","journal-title":"Int J Gynecol Cancer"},{"issue":"30","key":"5452_CR4","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1200\/JCO.2006.06.2489","volume":"24","author":"N Murugaesu","year":"2006","unstructured":"Murugaesu N, Schmid P, Dancey G, Agarwal R, Holden L, McNeish I, Savage PM, Newlands ES, Rustin GJ, Seckl MJ (2006) Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol 24(30):4862\u20134866","journal-title":"J Clin Oncol"},{"issue":"2","key":"5452_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1200\/JCO.1994.12.2.378","volume":"12","author":"E Segelov","year":"1994","unstructured":"Segelov E, Campbell J, Ng M et al (1994) Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol 12(2):378\u2013384","journal-title":"J Clin Oncol"},{"issue":"1","key":"5452_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/gyno.1998.5047","volume":"70","author":"MA Dimopoulos","year":"1998","unstructured":"Dimopoulos MA, Papadopoulou M, Andreopoulou E et al (1998) Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study. Gynecol Oncol 70(1):70\u201374","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5452_CR7","first-page":"138","volume":"89","author":"R Lertkhachonsuk","year":"2006","unstructured":"Lertkhachonsuk R, Manchana T, Termrungruanglert W, Vasuratna A, Sittisomwong T, Worasethsin P, Sirisabya N, Khemapech N, Tresukosol D (2006) Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 89(2):138\u2013144","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"5452_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ygyno.2004.08.018","volume":"95","author":"MA Dimopoulos","year":"2004","unstructured":"Dimopoulos MA, Papadimitriou C, Hamilos G et al (2004) Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study. Gynecol Oncol 95(3):695\u2013700","journal-title":"Gynecol Oncol"},{"key":"5452_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ygyno.2015.03.054","volume":"137","author":"JY Park","year":"2015","unstructured":"Park JY, Kim DY, Suh DS et al (2015) Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors. Gynecol Oncol 137:418\u2013422","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5452_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ygyno.2010.05.035","volume":"119","author":"G Mangili","year":"2010","unstructured":"Mangili G, Scarfone G, Gadducci A et al (2010) Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9). Gynecol Oncol 119(1):48\u201352","journal-title":"Gynecol Oncol"},{"issue":"6","key":"5452_CR11","first-page":"1020","volume":"76","author":"M Morris","year":"1990","unstructured":"Morris M, Gershenson DM, Burke TW et al (1990) Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 76(6):1020\u20131024","journal-title":"Obstet Gynecol"},{"issue":"4","key":"5452_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1200\/JCO.1994.12.4.701","volume":"12","author":"S Williams","year":"1994","unstructured":"Williams S, Blessing JA, Liao SY et al (1994) Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 12(4):701\u2013706","journal-title":"J Clin Oncol"},{"key":"5452_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11864-016-0416-2","volume":"17","author":"J Li","year":"2016","unstructured":"Li J, Xiaohua Wu (2016) Current strategy for the treatment of ovarian germ cell tumors role of extensive surgery. CurrTreat Options in Oncol 17:44","journal-title":"CurrTreat Options in Oncol"},{"issue":"3","key":"5452_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jog.12253","volume":"40","author":"EI Egemen","year":"2014","unstructured":"Egemen EI, Salih T, Rifat G et al (2014) Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors. J Obstet Gynaecol Res 40(3):797\u2013805","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"5452_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/00016340903443684","volume":"89","author":"T Siriwan","year":"2010","unstructured":"Siriwan T, Jitti H, Sumonmal M et al (2010) Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes. Acta Obstet Gynecol Scand 89(2):182\u2013189","journal-title":"Acta Obstet Gynecol Scand"},{"key":"5452_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejogrb.2015.06.017","volume":"192","author":"PV Reddihalli","year":"2015","unstructured":"Reddihalli PV, Subbian A, Umadevi K et al (2015) Immature teratoma of ovary\u2014outcome following primary and secondary surgery: study of a single institution cohort. Eur J Obstet Gynecol Reprod Biol 192:17\u201321","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"5452_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/gyno.1994.1280","volume":"55","author":"A Munkarah","year":"1994","unstructured":"Munkarah A, Gershenson DM, Levenback C et al (1994) Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol 55(2):217\u2013223","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5452_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ygyno.2007.02.032","volume":"105","author":"J Li","year":"2007","unstructured":"Li J, Yang W, Wu X (2007) Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Gynecol Oncol 105(3):769\u2013775","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5452_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000381771","volume":"81","author":"ZJ Yang","year":"2016","unstructured":"Yang ZJ, Liu ZC, Wei RJ, Li L (2016) An analysis of prognostic factors in patients with ovarian malignant germ cell tumors who are treated with fertility-preserving surgery. Gynecol Obstet Invest 81(1):1\u20139","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"5452_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcu.20905","volume":"40","author":"JL Alc\u00e1zar","year":"2012","unstructured":"Alc\u00e1zar JL, Guerriero S, Pascual M\u00c1 et al (2012) Clinical and sonographic features of uncommon primary ovarian malignancies. J Clin Ultrasound 40(6):323\u2013329","journal-title":"J Clin Ultrasound"},{"key":"5452_CR21","first-page":"219","volume":"41","author":"K Shen","year":"2006","unstructured":"Shen K (2006) Problems of fertility preservation treatment in gynecologic oncology. Zhonghua Fu Chan Ke Za Zhi 41:219\u2013221","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"5","key":"5452_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1200\/JOP.2016.011411","volume":"12","author":"S Rashdan","year":"2016","unstructured":"Rashdan S, Einhorn LH (2016) Salvage therapy for patients with germ cell tumor. J Oncol Pract 12(5):437\u2013443","journal-title":"J Oncol Pract"},{"issue":"3","key":"5452_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ygyno.2016.02.007","volume":"141","author":"CG Simone","year":"2016","unstructured":"Simone CG, Markham MJ, Dizon DS (2016) Chemotherapy in ovarian germ cell tumors: a systematic review. Gynecol Oncol 141(3):602\u2013607","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5452_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1200\/JCO.2014.59.4325","volume":"33","author":"NR Ammakkanavar","year":"2015","unstructured":"Ammakkanavar NR, Matei D, Abonour R et al (2015) High-dose chemotherapy for recurrent ovarian germ cell tumors. J Clin Oncol 33(2):226\u2013227","journal-title":"J Clin Oncol"},{"issue":"8","key":"5452_CR25","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/annonc\/mdx259","volume":"28","author":"U De Giorgi","year":"2017","unstructured":"De Giorgi U, Richard S, Badoglio M, Solid Tumoufrs Working Party (STWP) of the Group EBMT et al (2017) Salvage high-dose chemotherapy in female patients with relapsed\/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT). Ann Oncol 28(8):1910\u20131916","journal-title":"Ann Oncol"},{"issue":"2","key":"5452_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/annonc\/mdw563","volume":"28","author":"G Mangili","year":"2017","unstructured":"Mangili G, Sigismondi C, Lorusso D, Cormio G, Candiani M, Scarfone G, Mascilini F, Gadducci A, Mosconi AM, Scollo P, Cassani C, Pignata S, Ferrandina G (2017) The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study. Ann Oncol 28(2):333\u2013338","journal-title":"Ann Oncol"},{"issue":"2","key":"5452_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ygyno.2013.08.028","volume":"131","author":"O Solheim","year":"2013","unstructured":"Solheim O, K\u00e6rn J, Trop\u00e9 CG, Rokkones E, Dahl AA, Nesland JM, Foss\u00e5 SD (2013) Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953\u20132009). Gynecol Oncol 131(2):330\u2013335","journal-title":"Gynecol Oncol"},{"key":"5452_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/EdBook_AM.2013.33.e210","volume":"33","author":"D Matei","year":"2013","unstructured":"Matei D, Brown J, Frazier L (2013) Updates in the management of ovarian germ cell tumors. Am Soc Clin Oncol Educ Book 33:210\u2013218","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05452-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-020-05452-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05452-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:30:25Z","timestamp":1616200225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-020-05452-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5452"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05452-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]},"assertion":[{"value":"26 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declares that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}